Global Multivalent Influenza Vaccines Production, Demand and Key Producers, 2022-2028
This report studies the global Multivalent Influenza Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multivalent Influenza Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multivalent Influenza Vaccines that contribute to its increasing demand across many markets.
The global Multivalent Influenza Vaccines market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Multivalent Influenza Vaccines total production and demand, 2017-2028, (K Units)
Global Multivalent Influenza Vaccines total production value, 2017-2028, (USD Million)
Global Multivalent Influenza Vaccines production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Multivalent Influenza Vaccines domestic production, consumption, key domestic manufacturers and share
Global Multivalent Influenza Vaccines production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Multivalent Influenza Vaccines market based on the following parameters – headquarters, production locations, products portfolio, Multivalent Influenza Vaccines revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multivalent Influenza Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Multivalent Influenza Vaccines Market, By Region:
1. How big is the global Multivalent Influenza Vaccines market?
2. What is the demand of the global Multivalent Influenza Vaccines market?
3. What is the year over year growth of the global Multivalent Influenza Vaccines market?
4. What is the production and production value of the global Multivalent Influenza Vaccines market?
5. Who are the key producers in the global Multivalent Influenza Vaccines market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Multivalent Influenza Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multivalent Influenza Vaccines that contribute to its increasing demand across many markets.
The global Multivalent Influenza Vaccines market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Multivalent Influenza Vaccines total production and demand, 2017-2028, (K Units)
Global Multivalent Influenza Vaccines total production value, 2017-2028, (USD Million)
Global Multivalent Influenza Vaccines production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Multivalent Influenza Vaccines domestic production, consumption, key domestic manufacturers and share
Global Multivalent Influenza Vaccines production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Multivalent Influenza Vaccines market based on the following parameters – headquarters, production locations, products portfolio, Multivalent Influenza Vaccines revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multivalent Influenza Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Multivalent Influenza Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Trivalent Inactivated Influenza Vaccine (IIV3)
- Trivalent Live Attenuated Vaccine (LAIV3)
- Quadrivalent Inactivated Influenza Vaccine (IIV4)
- 6 Months to 3 Years
- Above 3 Years
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Bcht Biotechnology
- Jiangsu GDK
- KM Biologics
- ADIMMUNE Corporation
- Aleph Biomedical
- Shanghai Institute of Biological Products
- Zhongyianke Biotech
- Wuhan Institute of Biological Products
1. How big is the global Multivalent Influenza Vaccines market?
2. What is the demand of the global Multivalent Influenza Vaccines market?
3. What is the year over year growth of the global Multivalent Influenza Vaccines market?
4. What is the production and production value of the global Multivalent Influenza Vaccines market?
5. Who are the key producers in the global Multivalent Influenza Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Multivalent Influenza Vaccines Introduction
1.2 World Multivalent Influenza Vaccines Supply & Forecast
1.2.1 World Multivalent Influenza Vaccines Production Value (2017 & 2021 & 2028)
1.2.2 World Multivalent Influenza Vaccines Production (2017-2028)
1.2.3 World Multivalent Influenza Vaccines Pricing Trends (2017-2028)
1.3 World Multivalent Influenza Vaccines Production by Region
1.3.1 World Multivalent Influenza Vaccines Production Value by Region (2017-2028)
1.3.2 World Multivalent Influenza Vaccines Production by Region (2017-2028)
1.3.3 World Multivalent Influenza Vaccines Average Price by Region (2017-2028)
1.3.4 North America Multivalent Influenza Vaccines Production (2017-2028)
1.3.5 Europe Multivalent Influenza Vaccines Production (2017-2028)
1.3.6 China Multivalent Influenza Vaccines Production (2017-2028)
1.3.7 Japan Multivalent Influenza Vaccines Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multivalent Influenza Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Multivalent Influenza Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Multivalent Influenza Vaccines Demand (2017-2028)
2.2 World Multivalent Influenza Vaccines Consumption by Region
2.2.1 World Multivalent Influenza Vaccines Consumption by Region (2017-2022)
2.2.2 World Multivalent Influenza Vaccines Consumption Forecast by Region (2023-2028)
2.3 United States Multivalent Influenza Vaccines Consumption (2017-2028)
2.4 China Multivalent Influenza Vaccines Consumption (2017-2028)
2.5 Europe Multivalent Influenza Vaccines Consumption (2017-2028)
2.6 Japan Multivalent Influenza Vaccines Consumption (2017-2028)
2.7 South Korea Multivalent Influenza Vaccines Consumption (2017-2028)
2.8 ASEAN Multivalent Influenza Vaccines Consumption (2017-2028)
2.9 India Multivalent Influenza Vaccines Consumption (2017-2028)
3 WORLD MULTIVALENT INFLUENZA VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Multivalent Influenza Vaccines Production Value by Manufacturer (2017-2022)
3.2 World Multivalent Influenza Vaccines Production by Manufacturer (2017-2022)
3.3 World Multivalent Influenza Vaccines Average Price by Manufacturer (2017-2022)
3.4 Multivalent Influenza Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Multivalent Influenza Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Multivalent Influenza Vaccines in 2021
3.5.3 Global Concentration Ratios (CR8) for Multivalent Influenza Vaccines in 2021
3.6 Multivalent Influenza Vaccines Market: Overall Company Footprint Analysis
3.6.1 Multivalent Influenza Vaccines Market: Region Footprint
3.6.2 Multivalent Influenza Vaccines Market: Company Product Type Footprint
3.6.3 Multivalent Influenza Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison
4.1.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Multivalent Influenza Vaccines Production Comparison
4.2.1 United States VS China: Multivalent Influenza Vaccines Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Multivalent Influenza Vaccines Consumption Comparison
4.3.1 United States VS China: Multivalent Influenza Vaccines Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Multivalent Influenza Vaccines in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
4.5 China Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Multivalent Influenza Vaccines in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Multivalent Influenza Vaccines in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Multivalent Influenza Vaccines Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Trivalent Inactivated Influenza Vaccine (IIV3)
5.2.2 Trivalent Live Attenuated Vaccine (LAIV3)
5.2.3 Quadrivalent Inactivated Influenza Vaccine (IIV4)
5.3 Market Segment by Type
5.3.1 World Multivalent Influenza Vaccines Production by Type (2017-2028)
5.3.2 World Multivalent Influenza Vaccines Production Value by Type (2017-2028)
5.3.3 World Multivalent Influenza Vaccines Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Multivalent Influenza Vaccines Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 6 Months to 3 Years
6.2.2 Above 3 Years
6.3 Market Segment by Application
6.3.1 World Multivalent Influenza Vaccines Production by Application (2017-2028)
6.3.2 World Multivalent Influenza Vaccines Production Value by Application (2017-2028)
6.3.3 World Multivalent Influenza Vaccines Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Multivalent Influenza Vaccines Product and Services
7.1.4 Sanofi Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Multivalent Influenza Vaccines Product and Services
7.2.4 CSL Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Multivalent Influenza Vaccines Product and Services
7.3.4 GSK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Multivalent Influenza Vaccines Product and Services
7.4.4 Viatris Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Multivalent Influenza Vaccines Product and Services
7.5.4 AstraZeneca Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Multivalent Influenza Vaccines Product and Services
7.6.4 Hualan Bio Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
7.7.4 Changchun Institute of Biological Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Multivalent Influenza Vaccines Product and Services
7.8.4 Sinovac Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 Bcht Biotechnology
7.9.1 Bcht Biotechnology Details
7.9.2 Bcht Biotechnology Major Business
7.9.3 Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
7.9.4 Bcht Biotechnology Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Bcht Biotechnology Recent Developments/Updates
7.9.6 Bcht Biotechnology Competitive Strengths & Weaknesses
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Details
7.10.2 Jiangsu GDK Major Business
7.10.3 Jiangsu GDK Multivalent Influenza Vaccines Product and Services
7.10.4 Jiangsu GDK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Jiangsu GDK Recent Developments/Updates
7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
7.11 KM Biologics
7.11.1 KM Biologics Details
7.11.2 KM Biologics Major Business
7.11.3 KM Biologics Multivalent Influenza Vaccines Product and Services
7.11.4 KM Biologics Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 KM Biologics Recent Developments/Updates
7.11.6 KM Biologics Competitive Strengths & Weaknesses
7.12 ADIMMUNE Corporation
7.12.1 ADIMMUNE Corporation Details
7.12.2 ADIMMUNE Corporation Major Business
7.12.3 ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
7.12.4 ADIMMUNE Corporation Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 ADIMMUNE Corporation Recent Developments/Updates
7.12.6 ADIMMUNE Corporation Competitive Strengths & Weaknesses
7.13 Aleph Biomedical
7.13.1 Aleph Biomedical Details
7.13.2 Aleph Biomedical Major Business
7.13.3 Aleph Biomedical Multivalent Influenza Vaccines Product and Services
7.13.4 Aleph Biomedical Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Aleph Biomedical Recent Developments/Updates
7.13.6 Aleph Biomedical Competitive Strengths & Weaknesses
7.14 Shanghai Institute of Biological Products
7.14.1 Shanghai Institute of Biological Products Details
7.14.2 Shanghai Institute of Biological Products Major Business
7.14.3 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
7.14.4 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Shanghai Institute of Biological Products Recent Developments/Updates
7.14.6 Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
7.15 Zhongyianke Biotech
7.15.1 Zhongyianke Biotech Details
7.15.2 Zhongyianke Biotech Major Business
7.15.3 Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
7.15.4 Zhongyianke Biotech Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Zhongyianke Biotech Recent Developments/Updates
7.15.6 Zhongyianke Biotech Competitive Strengths & Weaknesses
7.16 Wuhan Institute of Biological Products
7.16.1 Wuhan Institute of Biological Products Details
7.16.2 Wuhan Institute of Biological Products Major Business
7.16.3 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
7.16.4 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.16.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Multivalent Influenza Vaccines and Key Manufacturers
8.2 Multivalent Influenza Vaccines Manufacturing Costs
8.3 Multivalent Influenza Vaccines Production Process
8.4 Multivalent Influenza Vaccines Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Multivalent Influenza Vaccines Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Multivalent Influenza Vaccines Typical Distributors
9.3 Multivalent Influenza Vaccines Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Multivalent Influenza Vaccines Introduction
1.2 World Multivalent Influenza Vaccines Supply & Forecast
1.2.1 World Multivalent Influenza Vaccines Production Value (2017 & 2021 & 2028)
1.2.2 World Multivalent Influenza Vaccines Production (2017-2028)
1.2.3 World Multivalent Influenza Vaccines Pricing Trends (2017-2028)
1.3 World Multivalent Influenza Vaccines Production by Region
1.3.1 World Multivalent Influenza Vaccines Production Value by Region (2017-2028)
1.3.2 World Multivalent Influenza Vaccines Production by Region (2017-2028)
1.3.3 World Multivalent Influenza Vaccines Average Price by Region (2017-2028)
1.3.4 North America Multivalent Influenza Vaccines Production (2017-2028)
1.3.5 Europe Multivalent Influenza Vaccines Production (2017-2028)
1.3.6 China Multivalent Influenza Vaccines Production (2017-2028)
1.3.7 Japan Multivalent Influenza Vaccines Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Multivalent Influenza Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Multivalent Influenza Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Multivalent Influenza Vaccines Demand (2017-2028)
2.2 World Multivalent Influenza Vaccines Consumption by Region
2.2.1 World Multivalent Influenza Vaccines Consumption by Region (2017-2022)
2.2.2 World Multivalent Influenza Vaccines Consumption Forecast by Region (2023-2028)
2.3 United States Multivalent Influenza Vaccines Consumption (2017-2028)
2.4 China Multivalent Influenza Vaccines Consumption (2017-2028)
2.5 Europe Multivalent Influenza Vaccines Consumption (2017-2028)
2.6 Japan Multivalent Influenza Vaccines Consumption (2017-2028)
2.7 South Korea Multivalent Influenza Vaccines Consumption (2017-2028)
2.8 ASEAN Multivalent Influenza Vaccines Consumption (2017-2028)
2.9 India Multivalent Influenza Vaccines Consumption (2017-2028)
3 WORLD MULTIVALENT INFLUENZA VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Multivalent Influenza Vaccines Production Value by Manufacturer (2017-2022)
3.2 World Multivalent Influenza Vaccines Production by Manufacturer (2017-2022)
3.3 World Multivalent Influenza Vaccines Average Price by Manufacturer (2017-2022)
3.4 Multivalent Influenza Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Multivalent Influenza Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Multivalent Influenza Vaccines in 2021
3.5.3 Global Concentration Ratios (CR8) for Multivalent Influenza Vaccines in 2021
3.6 Multivalent Influenza Vaccines Market: Overall Company Footprint Analysis
3.6.1 Multivalent Influenza Vaccines Market: Region Footprint
3.6.2 Multivalent Influenza Vaccines Market: Company Product Type Footprint
3.6.3 Multivalent Influenza Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison
4.1.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Multivalent Influenza Vaccines Production Comparison
4.2.1 United States VS China: Multivalent Influenza Vaccines Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Multivalent Influenza Vaccines Consumption Comparison
4.3.1 United States VS China: Multivalent Influenza Vaccines Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Multivalent Influenza Vaccines in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
4.5 China Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Multivalent Influenza Vaccines in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Multivalent Influenza Vaccines Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Multivalent Influenza Vaccines in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Multivalent Influenza Vaccines Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Trivalent Inactivated Influenza Vaccine (IIV3)
5.2.2 Trivalent Live Attenuated Vaccine (LAIV3)
5.2.3 Quadrivalent Inactivated Influenza Vaccine (IIV4)
5.3 Market Segment by Type
5.3.1 World Multivalent Influenza Vaccines Production by Type (2017-2028)
5.3.2 World Multivalent Influenza Vaccines Production Value by Type (2017-2028)
5.3.3 World Multivalent Influenza Vaccines Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Multivalent Influenza Vaccines Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 6 Months to 3 Years
6.2.2 Above 3 Years
6.3 Market Segment by Application
6.3.1 World Multivalent Influenza Vaccines Production by Application (2017-2028)
6.3.2 World Multivalent Influenza Vaccines Production Value by Application (2017-2028)
6.3.3 World Multivalent Influenza Vaccines Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Multivalent Influenza Vaccines Product and Services
7.1.4 Sanofi Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Multivalent Influenza Vaccines Product and Services
7.2.4 CSL Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Multivalent Influenza Vaccines Product and Services
7.3.4 GSK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Multivalent Influenza Vaccines Product and Services
7.4.4 Viatris Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Multivalent Influenza Vaccines Product and Services
7.5.4 AstraZeneca Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Multivalent Influenza Vaccines Product and Services
7.6.4 Hualan Bio Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
7.7.4 Changchun Institute of Biological Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Multivalent Influenza Vaccines Product and Services
7.8.4 Sinovac Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 Bcht Biotechnology
7.9.1 Bcht Biotechnology Details
7.9.2 Bcht Biotechnology Major Business
7.9.3 Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
7.9.4 Bcht Biotechnology Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Bcht Biotechnology Recent Developments/Updates
7.9.6 Bcht Biotechnology Competitive Strengths & Weaknesses
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Details
7.10.2 Jiangsu GDK Major Business
7.10.3 Jiangsu GDK Multivalent Influenza Vaccines Product and Services
7.10.4 Jiangsu GDK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Jiangsu GDK Recent Developments/Updates
7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
7.11 KM Biologics
7.11.1 KM Biologics Details
7.11.2 KM Biologics Major Business
7.11.3 KM Biologics Multivalent Influenza Vaccines Product and Services
7.11.4 KM Biologics Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 KM Biologics Recent Developments/Updates
7.11.6 KM Biologics Competitive Strengths & Weaknesses
7.12 ADIMMUNE Corporation
7.12.1 ADIMMUNE Corporation Details
7.12.2 ADIMMUNE Corporation Major Business
7.12.3 ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
7.12.4 ADIMMUNE Corporation Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 ADIMMUNE Corporation Recent Developments/Updates
7.12.6 ADIMMUNE Corporation Competitive Strengths & Weaknesses
7.13 Aleph Biomedical
7.13.1 Aleph Biomedical Details
7.13.2 Aleph Biomedical Major Business
7.13.3 Aleph Biomedical Multivalent Influenza Vaccines Product and Services
7.13.4 Aleph Biomedical Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Aleph Biomedical Recent Developments/Updates
7.13.6 Aleph Biomedical Competitive Strengths & Weaknesses
7.14 Shanghai Institute of Biological Products
7.14.1 Shanghai Institute of Biological Products Details
7.14.2 Shanghai Institute of Biological Products Major Business
7.14.3 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
7.14.4 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Shanghai Institute of Biological Products Recent Developments/Updates
7.14.6 Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
7.15 Zhongyianke Biotech
7.15.1 Zhongyianke Biotech Details
7.15.2 Zhongyianke Biotech Major Business
7.15.3 Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
7.15.4 Zhongyianke Biotech Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Zhongyianke Biotech Recent Developments/Updates
7.15.6 Zhongyianke Biotech Competitive Strengths & Weaknesses
7.16 Wuhan Institute of Biological Products
7.16.1 Wuhan Institute of Biological Products Details
7.16.2 Wuhan Institute of Biological Products Major Business
7.16.3 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
7.16.4 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.16.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Multivalent Influenza Vaccines and Key Manufacturers
8.2 Multivalent Influenza Vaccines Manufacturing Costs
8.3 Multivalent Influenza Vaccines Production Process
8.4 Multivalent Influenza Vaccines Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Multivalent Influenza Vaccines Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Multivalent Influenza Vaccines Typical Distributors
9.3 Multivalent Influenza Vaccines Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Multivalent Influenza Vaccines Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Multivalent Influenza Vaccines Production Value by Region (2017-2022) & (USD Million)
Table 3. World Multivalent Influenza Vaccines Production Value by Region (2023-2028) & (USD Million)
Table 4. World Multivalent Influenza Vaccines Production Value Market Share by Region (2017-2022)
Table 5. World Multivalent Influenza Vaccines Production Value Market Share by Region (2023-2028)
Table 6. World Multivalent Influenza Vaccines Production by Region (2017-2022) & (K Units)
Table 7. World Multivalent Influenza Vaccines Production by Region (2023-2028) & (K Units)
Table 8. World Multivalent Influenza Vaccines Production Market Share by Region (2017-2022)
Table 9. World Multivalent Influenza Vaccines Production Market Share by Region (2023-2028)
Table 10. World Multivalent Influenza Vaccines Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Multivalent Influenza Vaccines Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Multivalent Influenza Vaccines Major Market Trends
Table 13. World Multivalent Influenza Vaccines Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Multivalent Influenza Vaccines Consumption by Region (2017-2022) & (K Units)
Table 15. World Multivalent Influenza Vaccines Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Multivalent Influenza Vaccines Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Multivalent Influenza Vaccines Producers in 2021
Table 18. World Multivalent Influenza Vaccines Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Multivalent Influenza Vaccines Producers in 2021
Table 20. World Multivalent Influenza Vaccines Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Multivalent Influenza Vaccines Company Evaluation Quadrant
Table 22. World Multivalent Influenza Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Multivalent Influenza Vaccines Production Site of Key Manufacturer
Table 24. Multivalent Influenza Vaccines Market: Company Product Type Footprint
Table 25. Multivalent Influenza Vaccines Market: Company Product Application Footprint
Table 26. Multivalent Influenza Vaccines Competitive Factors
Table 27. Multivalent Influenza Vaccines New Entrant and Capacity Expansion Plans
Table 28. Multivalent Influenza Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Multivalent Influenza Vaccines Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Multivalent Influenza Vaccines Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Multivalent Influenza Vaccines Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Multivalent Influenza Vaccines in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Multivalent Influenza Vaccines in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Multivalent Influenza Vaccines in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Multivalent Influenza Vaccines Production by Type (2017-2022) & (K Units)
Table 49. World Multivalent Influenza Vaccines Production by Type (2023-2028) & (K Units)
Table 50. World Multivalent Influenza Vaccines Production Value by Type (2017-2022) & (USD Million)
Table 51. World Multivalent Influenza Vaccines Production Value by Type (2023-2028) & (USD Million)
Table 52. World Multivalent Influenza Vaccines Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Multivalent Influenza Vaccines Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Multivalent Influenza Vaccines Production by Application (2017-2022) & (K Units)
Table 56. World Multivalent Influenza Vaccines Production by Application (2023-2028) & (K Units)
Table 57. World Multivalent Influenza Vaccines Production Value by Application (2017-2022) & (USD Million)
Table 58. World Multivalent Influenza Vaccines Production Value by Application (2023-2028) & (USD Million)
Table 59. World Multivalent Influenza Vaccines Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Multivalent Influenza Vaccines Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Multivalent Influenza Vaccines Product and Services
Table 64. Sanofi Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Major Business
Table 69. CSL Multivalent Influenza Vaccines Product and Services
Table 70. CSL Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. CSL Recent Developments/Updates
Table 72. CSL Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Multivalent Influenza Vaccines Product and Services
Table 76. GSK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Viatris Basic Information, Manufacturing Base and Competitors
Table 80. Viatris Major Business
Table 81. Viatris Multivalent Influenza Vaccines Product and Services
Table 82. Viatris Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Viatris Recent Developments/Updates
Table 84. Viatris Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Multivalent Influenza Vaccines Product and Services
Table 88. AstraZeneca Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Multivalent Influenza Vaccines Product and Services
Table 94. Hualan Bio Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 98. Changchun Institute of Biological Major Business
Table 99. Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
Table 100. Changchun Institute of Biological Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Changchun Institute of Biological Recent Developments/Updates
Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Major Business
Table 105. Sinovac Multivalent Influenza Vaccines Product and Services
Table 106. Sinovac Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Sinovac Recent Developments/Updates
Table 108. Sinovac Competitive Strengths & Weaknesses
Table 109. Bcht Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Bcht Biotechnology Major Business
Table 111. Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
Table 112. Bcht Biotechnology Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Bcht Biotechnology Recent Developments/Updates
Table 114. Bcht Biotechnology Competitive Strengths & Weaknesses
Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu GDK Major Business
Table 117. Jiangsu GDK Multivalent Influenza Vaccines Product and Services
Table 118. Jiangsu GDK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. Jiangsu GDK Competitive Strengths & Weaknesses
Table 121. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 122. KM Biologics Major Business
Table 123. KM Biologics Multivalent Influenza Vaccines Product and Services
Table 124. KM Biologics Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. KM Biologics Recent Developments/Updates
Table 126. KM Biologics Competitive Strengths & Weaknesses
Table 127. ADIMMUNE Corporation Basic Information, Manufacturing Base and Competitors
Table 128. ADIMMUNE Corporation Major Business
Table 129. ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
Table 130. ADIMMUNE Corporation Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. ADIMMUNE Corporation Recent Developments/Updates
Table 132. ADIMMUNE Corporation Competitive Strengths & Weaknesses
Table 133. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 134. Aleph Biomedical Major Business
Table 135. Aleph Biomedical Multivalent Influenza Vaccines Product and Services
Table 136. Aleph Biomedical Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Aleph Biomedical Recent Developments/Updates
Table 138. Aleph Biomedical Competitive Strengths & Weaknesses
Table 139. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 140. Shanghai Institute of Biological Products Major Business
Table 141. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
Table 142. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Shanghai Institute of Biological Products Recent Developments/Updates
Table 144. Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
Table 145. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Zhongyianke Biotech Major Business
Table 147. Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
Table 148. Zhongyianke Biotech Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Zhongyianke Biotech Recent Developments/Updates
Table 150. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 151. Wuhan Institute of Biological Products Major Business
Table 152. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
Table 153. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Multivalent Influenza Vaccines Raw Material
Table 155. Key Manufacturers of Multivalent Influenza Vaccines Raw Materials
Table 156. Multivalent Influenza Vaccines Typical Distributors
Table 157. Multivalent Influenza Vaccines Typical Customers
Table 1. World Multivalent Influenza Vaccines Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Multivalent Influenza Vaccines Production Value by Region (2017-2022) & (USD Million)
Table 3. World Multivalent Influenza Vaccines Production Value by Region (2023-2028) & (USD Million)
Table 4. World Multivalent Influenza Vaccines Production Value Market Share by Region (2017-2022)
Table 5. World Multivalent Influenza Vaccines Production Value Market Share by Region (2023-2028)
Table 6. World Multivalent Influenza Vaccines Production by Region (2017-2022) & (K Units)
Table 7. World Multivalent Influenza Vaccines Production by Region (2023-2028) & (K Units)
Table 8. World Multivalent Influenza Vaccines Production Market Share by Region (2017-2022)
Table 9. World Multivalent Influenza Vaccines Production Market Share by Region (2023-2028)
Table 10. World Multivalent Influenza Vaccines Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Multivalent Influenza Vaccines Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Multivalent Influenza Vaccines Major Market Trends
Table 13. World Multivalent Influenza Vaccines Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Multivalent Influenza Vaccines Consumption by Region (2017-2022) & (K Units)
Table 15. World Multivalent Influenza Vaccines Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Multivalent Influenza Vaccines Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Multivalent Influenza Vaccines Producers in 2021
Table 18. World Multivalent Influenza Vaccines Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Multivalent Influenza Vaccines Producers in 2021
Table 20. World Multivalent Influenza Vaccines Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Multivalent Influenza Vaccines Company Evaluation Quadrant
Table 22. World Multivalent Influenza Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Multivalent Influenza Vaccines Production Site of Key Manufacturer
Table 24. Multivalent Influenza Vaccines Market: Company Product Type Footprint
Table 25. Multivalent Influenza Vaccines Market: Company Product Application Footprint
Table 26. Multivalent Influenza Vaccines Competitive Factors
Table 27. Multivalent Influenza Vaccines New Entrant and Capacity Expansion Plans
Table 28. Multivalent Influenza Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Multivalent Influenza Vaccines Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Multivalent Influenza Vaccines Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Multivalent Influenza Vaccines Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Multivalent Influenza Vaccines in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Multivalent Influenza Vaccines in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Multivalent Influenza Vaccines in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Multivalent Influenza Vaccines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Multivalent Influenza Vaccines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Multivalent Influenza Vaccines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Multivalent Influenza Vaccines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Multivalent Influenza Vaccines Production by Type (2017-2022) & (K Units)
Table 49. World Multivalent Influenza Vaccines Production by Type (2023-2028) & (K Units)
Table 50. World Multivalent Influenza Vaccines Production Value by Type (2017-2022) & (USD Million)
Table 51. World Multivalent Influenza Vaccines Production Value by Type (2023-2028) & (USD Million)
Table 52. World Multivalent Influenza Vaccines Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Multivalent Influenza Vaccines Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Multivalent Influenza Vaccines Production by Application (2017-2022) & (K Units)
Table 56. World Multivalent Influenza Vaccines Production by Application (2023-2028) & (K Units)
Table 57. World Multivalent Influenza Vaccines Production Value by Application (2017-2022) & (USD Million)
Table 58. World Multivalent Influenza Vaccines Production Value by Application (2023-2028) & (USD Million)
Table 59. World Multivalent Influenza Vaccines Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Multivalent Influenza Vaccines Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Multivalent Influenza Vaccines Product and Services
Table 64. Sanofi Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Major Business
Table 69. CSL Multivalent Influenza Vaccines Product and Services
Table 70. CSL Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. CSL Recent Developments/Updates
Table 72. CSL Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Multivalent Influenza Vaccines Product and Services
Table 76. GSK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Viatris Basic Information, Manufacturing Base and Competitors
Table 80. Viatris Major Business
Table 81. Viatris Multivalent Influenza Vaccines Product and Services
Table 82. Viatris Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Viatris Recent Developments/Updates
Table 84. Viatris Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Multivalent Influenza Vaccines Product and Services
Table 88. AstraZeneca Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Multivalent Influenza Vaccines Product and Services
Table 94. Hualan Bio Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 98. Changchun Institute of Biological Major Business
Table 99. Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
Table 100. Changchun Institute of Biological Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Changchun Institute of Biological Recent Developments/Updates
Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Major Business
Table 105. Sinovac Multivalent Influenza Vaccines Product and Services
Table 106. Sinovac Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Sinovac Recent Developments/Updates
Table 108. Sinovac Competitive Strengths & Weaknesses
Table 109. Bcht Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Bcht Biotechnology Major Business
Table 111. Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
Table 112. Bcht Biotechnology Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Bcht Biotechnology Recent Developments/Updates
Table 114. Bcht Biotechnology Competitive Strengths & Weaknesses
Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu GDK Major Business
Table 117. Jiangsu GDK Multivalent Influenza Vaccines Product and Services
Table 118. Jiangsu GDK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. Jiangsu GDK Competitive Strengths & Weaknesses
Table 121. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 122. KM Biologics Major Business
Table 123. KM Biologics Multivalent Influenza Vaccines Product and Services
Table 124. KM Biologics Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. KM Biologics Recent Developments/Updates
Table 126. KM Biologics Competitive Strengths & Weaknesses
Table 127. ADIMMUNE Corporation Basic Information, Manufacturing Base and Competitors
Table 128. ADIMMUNE Corporation Major Business
Table 129. ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
Table 130. ADIMMUNE Corporation Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. ADIMMUNE Corporation Recent Developments/Updates
Table 132. ADIMMUNE Corporation Competitive Strengths & Weaknesses
Table 133. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 134. Aleph Biomedical Major Business
Table 135. Aleph Biomedical Multivalent Influenza Vaccines Product and Services
Table 136. Aleph Biomedical Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Aleph Biomedical Recent Developments/Updates
Table 138. Aleph Biomedical Competitive Strengths & Weaknesses
Table 139. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 140. Shanghai Institute of Biological Products Major Business
Table 141. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
Table 142. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Shanghai Institute of Biological Products Recent Developments/Updates
Table 144. Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
Table 145. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Zhongyianke Biotech Major Business
Table 147. Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
Table 148. Zhongyianke Biotech Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Zhongyianke Biotech Recent Developments/Updates
Table 150. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 151. Wuhan Institute of Biological Products Major Business
Table 152. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
Table 153. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Multivalent Influenza Vaccines Raw Material
Table 155. Key Manufacturers of Multivalent Influenza Vaccines Raw Materials
Table 156. Multivalent Influenza Vaccines Typical Distributors
Table 157. Multivalent Influenza Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Multivalent Influenza Vaccines Picture
Figure 2. World Multivalent Influenza Vaccines Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Multivalent Influenza Vaccines Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 5. World Multivalent Influenza Vaccines Average Price (2017-2028) & (US$/Unit)
Figure 6. World Multivalent Influenza Vaccines Production Value Market Share by Region (2017-2028)
Figure 7. World Multivalent Influenza Vaccines Production Market Share by Region (2017-2028)
Figure 8. North America Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 9. Europe Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 10. China Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 11. Japan Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 12. Multivalent Influenza Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Multivalent Influenza Vaccines Demand (2017-2028) & (K Units)
Figure 15. World Multivalent Influenza Vaccines Consumption Market Share by Region (2017-2028)
Figure 16. United States Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 17. China Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 18. Europe Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 19. Japan Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 20. South Korea Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 22. India Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Multivalent Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Multivalent Influenza Vaccines Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Multivalent Influenza Vaccines Markets in 2021
Figure 26. United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Multivalent Influenza Vaccines in United States
Figure 30. Key Producers and Market Share of Multivalent Influenza Vaccines in China
Figure 31. Key Producers and Market Share of Multivalent Influenza Vaccines in Rest of World
Figure 32. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Multivalent Influenza Vaccines Production Value Market Share by Type in 2021
Figure 34. Trivalent Inactivated Influenza Vaccine (IIV3)
Figure 35. Trivalent Live Attenuated Vaccine (LAIV3)
Figure 36. Quadrivalent Inactivated Influenza Vaccine (IIV4)
Figure 37. World Multivalent Influenza Vaccines Production Market Share by Type (2017-2028)
Figure 38. World Multivalent Influenza Vaccines Production Value Market Share by Type (2017-2028)
Figure 39. World Multivalent Influenza Vaccines Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Multivalent Influenza Vaccines Production Value Market Share by Application in 2021
Figure 42. 6 Months to 3 Years
Figure 43. Above 3 Years
Figure 44. World Multivalent Influenza Vaccines Production Market Share by Application (2017-2028)
Figure 45. World Multivalent Influenza Vaccines Production Value Market Share by Application (2017-2028)
Figure 46. World Multivalent Influenza Vaccines Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Multivalent Influenza Vaccines in 2021
Figure 48. Manufacturing Process Analysis of Multivalent Influenza Vaccines
Figure 49. Multivalent Influenza Vaccines Industrial Chain
Figure 50. Distribution Channel Breakdown for Multivalent Influenza Vaccines Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Multivalent Influenza Vaccines Picture
Figure 2. World Multivalent Influenza Vaccines Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Multivalent Influenza Vaccines Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 5. World Multivalent Influenza Vaccines Average Price (2017-2028) & (US$/Unit)
Figure 6. World Multivalent Influenza Vaccines Production Value Market Share by Region (2017-2028)
Figure 7. World Multivalent Influenza Vaccines Production Market Share by Region (2017-2028)
Figure 8. North America Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 9. Europe Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 10. China Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 11. Japan Multivalent Influenza Vaccines Production (2017-2028) & (K Units)
Figure 12. Multivalent Influenza Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Multivalent Influenza Vaccines Demand (2017-2028) & (K Units)
Figure 15. World Multivalent Influenza Vaccines Consumption Market Share by Region (2017-2028)
Figure 16. United States Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 17. China Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 18. Europe Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 19. Japan Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 20. South Korea Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 22. India Multivalent Influenza Vaccines Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Multivalent Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Multivalent Influenza Vaccines Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Multivalent Influenza Vaccines Markets in 2021
Figure 26. United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Multivalent Influenza Vaccines in United States
Figure 30. Key Producers and Market Share of Multivalent Influenza Vaccines in China
Figure 31. Key Producers and Market Share of Multivalent Influenza Vaccines in Rest of World
Figure 32. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Multivalent Influenza Vaccines Production Value Market Share by Type in 2021
Figure 34. Trivalent Inactivated Influenza Vaccine (IIV3)
Figure 35. Trivalent Live Attenuated Vaccine (LAIV3)
Figure 36. Quadrivalent Inactivated Influenza Vaccine (IIV4)
Figure 37. World Multivalent Influenza Vaccines Production Market Share by Type (2017-2028)
Figure 38. World Multivalent Influenza Vaccines Production Value Market Share by Type (2017-2028)
Figure 39. World Multivalent Influenza Vaccines Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Multivalent Influenza Vaccines Production Value Market Share by Application in 2021
Figure 42. 6 Months to 3 Years
Figure 43. Above 3 Years
Figure 44. World Multivalent Influenza Vaccines Production Market Share by Application (2017-2028)
Figure 45. World Multivalent Influenza Vaccines Production Value Market Share by Application (2017-2028)
Figure 46. World Multivalent Influenza Vaccines Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Multivalent Influenza Vaccines in 2021
Figure 48. Manufacturing Process Analysis of Multivalent Influenza Vaccines
Figure 49. Multivalent Influenza Vaccines Industrial Chain
Figure 50. Distribution Channel Breakdown for Multivalent Influenza Vaccines Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
